This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Alzheimer Disease or Cognitive Impairment
and you are
between 50 and 85
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The primary purpose of this study is to determine whether sodium oligo-mannurarate capsule is effective and safe in the treatment of mild to moderate alzheimer' disease, and to determine the best therapeutic dose of sodium oligo-mannurarate capsule.

Provided treatments

  • Drug: Sodium oligo-mannurarate 600mg
  • Drug: Sodium oligo-mannurarate 900mg
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01453569. The sponsor of the trial is Shanghai Greenvalley Pharmaceutical Co., Ltd. and it is looking for 255 volunteers for the current phase.
Official trial title:
Phase II Study of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer Disease